Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025BloodOpen Access

An actionable DNA repair defect in myeloid malignancies with U2AF1 S34 mutations

View Full Paper
Ask AI
Bookmark
Share

Authors

SAShuhei AsadaYHYuna Hirohashi

Discussion

Loading...

Member takes

Overview

Analysis shows genotoxic stress response and exon 7 skipping in myeloid malignancies, indicating potential therapeutic targets for U2AF1 S34 mutations.

Key Points

  • Myeloid malignancies with U2AF1 S34 mutations showed functional deficiencies in DNA repair mechanisms, particularly MMEJ.
  • Cells carrying the S34 mutation exhibited heightened sensitivity to inhibitors targeting DNA repair pathways.
  • Analysis of RNA-seq data identified reduced POLQ levels linked to exon 7 skipping as a consequence of U2AF1 mutations.
  • These findings suggest synthetic lethality as a viable therapeutic approach in cancers harboring U2AF1 S34 mutations.

Cite This Study

Asada et al. (2025) studied this question.

synapsesocial.com/papers/69362f5d4fa91c937236dc46https://doi.org/10.1182/blood-2025-215
View Full Paper
Ask AI
Bookmark
Share